1. Medtech Insight
  2. >>Policy & Regulation

AdvaMed Presses CMS On Open Payments Context, Dispute Resolutions

As CMS moves forward to implement its Open Payments systems on physician payment reporting by month’s end, AdvaMed presses the agency to say how much contextual information will be included with the reports, and to make the system’s dispute and resolution process more efficient.

AdvaMed asked CMS in Aug. 29 comments to address some lingering “open issues” that remain with the agency’s Open Payments system for manufacturers’ public reports on their physician payments. The group pushed the agency to spell out what type of contextual information will be permitted on the website, and laid out a number of inefficiencies and problems with the Open Payments dispute resolution process that it asked CMS to resolve before the system goes live Sept. 30.

CMS has not yet released information regarding “background information on the nature of relationships between physicians and teaching hospitals and industry,” wrote AdvaMed’s Senior Executive VP, General Counsel Christopher White.

More from Regulation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.